GENERATION BIO CO. - COMMON STOCK

Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases

06 Jan 2025 15:30:00 By Nasdaq GlobeNewswire

Generation Bio Reports Recent Business Highlights and Third Quarter 2024 Financial Results

06 Nov 2024 15:05:00 By Nasdaq GlobeNewswire

Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress

22 Oct 2024 05:59:00 By Nasdaq GlobeNewswire

Generation Bio to Present at the 2024 Cantor Global Healthcare Conference

12 Sep 2024 15:05:00 By Nasdaq GlobeNewswire

Generation Bio Reports Second Quarter 2024 Financial Results

07 Aug 2024 15:05:00 By Nasdaq GlobeNewswire

Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference

06 Aug 2024 05:59:00 By Nasdaq GlobeNewswire

Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit

14 Jun 2024 05:59:00 By Nasdaq GlobeNewswire

Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results

13 May 2024 15:05:00 By Nasdaq GlobeNewswire

Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting

09 May 2024 05:59:00 By Nasdaq GlobeNewswire

Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

22 Apr 2024 16:31:01 By Nasdaq GlobeNewswire

Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference

02 Apr 2024 05:59:00 By Nasdaq GlobeNewswire

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

06 Mar 2024 15:20:00 By Nasdaq GlobeNewswire

Generation Bio to Present at the 2024 TD Cowen Health Care Conference

27 Feb 2024 05:59:00 By Nasdaq GlobeNewswire

Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference

03 Jan 2024 15:05:00 By Nasdaq GlobeNewswire

Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms

29 Nov 2023 05:59:00 By Nasdaq GlobeNewswire

Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results

09 Nov 2023 15:15:00 By Nasdaq GlobeNewswire

Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform

26 Oct 2023 05:59:00 By Nasdaq GlobeNewswire

Generation Bio Announces Breakthrough in its Non-Viral Genetic Medicine Platform with Novel “Immune-Quiet” DNA

18 Oct 2023 05:59:16 By Nasdaq GlobeNewswire

Generation Bio to Present at the Jefferies Cell & Genetic Medicine Summit

19 Sep 2023 06:30:00 By Nasdaq GlobeNewswire

Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference 

03 Aug 2023 06:30:00 By Nasdaq GlobeNewswire